产品展示更多>>
- Nicotinamide 98-92-0

- Nicotinamide 98-92-0
Nicotinamide 98-92-0
产品描述 描述 Nicotinamide (Vitamin B3), a water-soluble vitamin, is an active component of coenzymes NAD and NADP, and also act as an activator of sirtuins.
纯度 >98%储存/保存方法 Store at -20℃ for one year(Powder);Store at 2-4℃ for two weeks;Store at -20℃ for six months after dissolution.基本信息 别名 yan酰胺;Niacinamide;Nicotinic acid amide; Vitamin B3外观 白色针状结晶或结晶性粉末可溶性/溶解性
DMSO : 23 mg/mL (188.3 mM)
Ethanol : 23 mg/mL (188.3 mM)
Water : 22 mg/mL (180.2 mM)生物活性 靶点 SirtuinIn vitro(体外研究) Nicotinamide strongly inhibits yeast silencing, increases rDNA recombination, and shortens replicative life span to that of a sir2 mutant. Nicotinamide abolishes silencing and leads to an eventual delocalization of Sir2 even in G(1)-arrested cells, demonstrating that silent heterochromatin requires continual Sir2 activity. Nicotinamide results in a twofold increase in DNA content and a threefold increase in insulin content in the fetal cells. Nicotinamide induces differentiation and maturation of human fetal pancreatic islet cells. Nicotinamide regulates sirtuins by switching between deacetylation and base exchange. Nicotinamide switching is quantitated for the Sir2s from Archeaglobus fulgidus (Sir2Af2), Saccharomyces cerevisiae (Sir2p), and mouse (Sir2alpha). Nicotinamide selectively reduces a specific phospho-species of tau (Thr231) that is associated with microtubule depolymerization in Alzheimer's disease transgenic mice, in a manner similar to inhibition of SirT1. Nicotinamide also dramatically increases acetylated alpha-tubulin, a primary substrate of SirT2, and MAP2c in Alzheimer's disease transgenic mice, both of which are linked to increased microtubule stability. Nicotinamide fosters DNA integrity and maintains phosphatidylserine membrane asymmetry to prevent cellular inflammation, cellular phagocytosis and vascular thrombosis. Nicotinamide both prevents and reverses neuronal and vascular cell injury.In vivo(体内研究) In the mouse, nicotinamide given i.p. at doses of 100-500 mg/kg showed biphasic elimination with dose-dependent changes in half-life. The initial half-life increased significantly (P .参考文献 参考文献 1. Bitterman KJ, et al. J Biol Chem, 2002, 277(47), 45099-45107.
2. Otonkoski T, et al. J Clin Invest, 1993, 92(3), 1459-1466.
3. Maiese K, et al. Trends Pharmacol Sci, 2003, 24(5), 228-232.
研究领域 研究领域 EpigeneticsChromatin Modifying EnzymesAcetylationEpigeneticsChromatin Modifying EnzymesAcetylationHDACsClass ISignal TransductionCytoskeleton / ECMCytoskeletonMicrotubulesTubulinDrug DiscoverySmall Molecule DrugLead Compound DiscoveryNicotinamide 98-92-0温馨提示:本产品仅作科研实验使用,不支持临床等研究
